Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lets 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Samarth Life Sciences Pvt Ltd

Salt Composition

Letrozole (2.5mg)

Overview Lets 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Lets 2.5mg Tablet. This medication can be administered independently or in conjunction with other therapies like surgery or radiation. It's also indicated for advanced breast cancer to inhibit metastasis. Lets 2.5mg Tablet can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage frequency is tailored to individual needs and determined by your doctor based on your specific condition and response to treatment. Continuous use, as directed, is crucial. Commonly reported side effects include sweating, tiredness, hot flushes, and elevated cholesterol. Report any concerning side effects to your physician immediately; management strategies are often available. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you are currently using, as drug interactions may impact efficacy. Disclose your pregnancy or breastfeeding status to your physician. Baseline and ongoing blood tests monitoring vitamin D levels and bone density may be conducted throughout the treatment course.

Uses of Lets 2.5mg Tablet

Managing breast cancer

Major Benefits of Lets 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. The 2.5mg Lets tablet can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Lets 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Lets 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The 2.5mg Lets tablet can be consumed with or without food, although consistent timing is recommended.

How Lets 2.5mg Tablet works:

Each 2.5mg Lets tablet functions as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Lets 2.5mg Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

Using Lets 2.5mg tablets during pregnancy is strongly discouraged due to substantial risks. Pregnant women should consult their physician, as research in both animals and pregnant humans reveals significant adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Using Lets 2.5mg tablets while breastfeeding is inadvisable due to potential infant toxicity. Research indicates a risk of harm to the nursing child.

DrivingDrivingUNSAFE

Taking a 2.5mg Lets tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving is discouraged if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The 2.5mg Lets Tablet is considered safe for patients with kidney disease, and no dosage modification is typically advised. Limited data exists, however, regarding its use in individuals with end-stage renal disease. Physician consultation is recommended.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Lets 2.5mg Tablet. Dosage modification for Lets 2.5mg Tablet may be necessary. Physician consultation is advised.

What if you forget to take Lets 2.5mg Tablet :

Should you forget a Lets 2.5mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lets 2.5mg Tablet

LabelValue
Chemical Type Diphenylmethane compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Lets 2.5mg Tablet

Lets 2.5mg Tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letrozole 2.5mg tablets are anti-estrogen medications. They work by inhibiting aromatase, an enzyme that produces estrogen. Since estrogen fuels the growth of some breast cancers (termed "estrogen-dependent cancers"), lowering estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue taking Lets 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Lets 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Lets 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Lets 2.5mg Tablet can be taken together, closely monitor your blood pressure as Lets 2.5mg Tablet may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Lets 2.5mg Tablet may lead to cataracts. Report blurred vision or eye irritation to your doctor promptly.
Experiencing hot flushes may indicate a common side effect of Lets 2.5mg Tablet, related to decreased estrogen. These usually lessen as your body adapts, but may persist throughout treatment, often subsiding a few months afterward. Consult your doctor if the hot flushes are severe.
While rare, Lets 2.5mg Tablet may cause serious side effects in some individuals. These include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Taking Lets 2.5mg Tablets may lead to bone thinning (osteoporosis) because of reduced estrogen. Your doctor might monitor your bone density before, during, and after treatment to check for osteoporosis.
The Ministry of Health and Family Welfare restricts Lets 2.5mg Tablets to inducing ovulation in women with anovulatory infertility.
Lets 2.5mg Tablet
126
MRP 146
13% off